000			02040 a2200613 4500
005			20250516173019.0
264		0	_c20140220
008			201402s 0 0 eng d
022			_a1532-1827
024	7		_a10.1038/bjc.2013.609 _2doi
040			_aNLM _beng _cNLM
100	1		_aBartlett, J M S
245	0	0	_aDo type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial. _h[electronic resource]
260			_bBritish journal of cancer _cOct 2013
300			_a2453-61 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAndrostadienes _xtherapeutic use
650	0	4	_aAromatase Inhibitors _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xmetabolism
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aDisease-Free Survival
650	0	4	_aErbB Receptors _xmetabolism
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Sequence Data
650	0	4	_aPrognosis
650	0	4	_aProspective Studies
650	0	4	_aReceptors, Estrogen _xmetabolism
650	0	4	_aReceptors, Progesterone _xmetabolism
650	0	4	_aSelective Estrogen Receptor Modulators _xtherapeutic use
650	0	4	_aTamoxifen _xtherapeutic use
650	0	4	_aTissue Array Analysis
700	1		_aBrookes, C L
700	1		_aPiper, T
700	1		_avan de Velde, C J H
700	1		_aStocken, D
700	1		_aLyttle, N
700	1		_aHasenburg, A
700	1		_aQuintayo, M A
700	1		_aKieback, D G
700	1		_aPutter, H
700	1		_aMarkopoulos, C
700	1		_aKranenbarg, E M-K
700	1		_aMallon, E A
700	1		_aDirix, L Y
700	1		_aSeynaeve, C
700	1		_aRea, D W
773	0		_tBritish journal of cancer _gvol. 109 _gno. 9 _gp. 2453-61
856	4	0	_uhttps://doi.org/10.1038/bjc.2013.609 _zAvailable from publisher's website
999			_c23139750 _d23139750